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A B S T R A C T
Purpose: Progressive myoclonic epilepsies (PME) include a heterogeneous group of disorders. The
brainstem is involved in these disorders, as demonstrated by neuroimaging and autopsy studies. The
blink reﬂex (BR) is characteristically elicited after supraorbital electrical stimulation. The BR has two
components, an ipsilateral R1 and bilateral R2 (R2 and R2c). The central generator of the BR is the
brainstem. In this study, we aimed to investigate the functional status of the brainstem using the BR in
PME cases with different etiological factors.
Methods: We prospectively included 17 patients with a diagnosis of PME (8 male, 47.1%) who were
examined between June 2009 and June 2012. For comparison, we included 41 healthy volunteers (18
male 43.9%) who did not have any neurological or systemic diseases. We recorded responses bilaterally
over the orbicularis oculi muscles after supraorbital stimulation in all participants.
Results: The R1 and R2 components of the BR were obtained in all healthy subjects with normal latencies,
whereas abnormalities in the R2 and R2c components were observed at signiﬁcantly higher rates in the
PME patients. The mean latencies of the bilateral R2 and R2c components were signiﬁcantly prolonged,
and the amplitudes were diminished in the PME patients. Disease duration and the use of multiple
antiepileptic drugs were related to abnormal R2s.
Conclusion: The abnormalities of the R2 and R2c components of the BR conﬁrmed the inhibition of the
reticular formation. The ﬁndings are probably related to disease processes and partially due to the use of
multiple antiepileptic drugs.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Progressive myoclonic epilepsies (PMEs) include a heteroge-
neous group of rare disorders that are generally transmitted via
autosomal recessive inheritance and present with myoclonus as
the core symptom accompanied by other types of seizures,
progressive neurocognitive decline, ataxia, and systemic features
[1]. Miscellaneous etiological factors may lead to PME, some of
which include Unverricht–Lundborg disease (ULD), Lafora disease
(LD), myoclonus epilepsy with ragged-red ﬁbers (MERRF),Abbreviations: PME, Progressive myoclonic epilepsy; ULD, Unverricht–Lundborg
disease; LD, Lafora disease; MERRF, Myoclonus epilepsy with ragged-red ﬁbers;
DRPLA, Dentato-rubro-pallido-luysian-atrophy; NCL, Neuronal ceroid lipofuscino-
sis; MRI, Magnetic resonance imaging; BR, Blink reﬂex; AED, Antiepileptic drugs;
EEG, Electroencephalography; SEP, Somatosensory evoked potentials; GTCS,
Generalized tonic-clonic seizures.
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neuronal ceroid lipofuscinosis (NCL).
Widespread pathologies of the central nervous system have
been shown in PME; however, evidence regarding the involved
pathways in the brainstem is still limited. DRPLA typically involves
the brainstem, and pathological studies have conﬁrmed the loss of
acetylcholinergic neurons in the pedunculopontine nucleus [2].
Magnetic resonance imaging (MRI) and spectroscopy ﬁndings
support the loss of neurons in the pons, medulla and cerebellum in
PME due to other causes [3,4].
Among the electrophysiological investigations that have been
conducted, brainstem-evoked potentials have been applied, and
the results have revealed reduced or absent brainstem components
as well as prolonged latencies and central transmission periods
[5,6]. In contrast, the blink reﬂex (BR) has been studied in MERRF
and found to be suppressed [7]. The BR is characteristically elicited
after supraorbital electrical stimulation via an afferent pathway
through the trigeminal nerve and an efferent pathway through the
facial nerve. Two components of the BR, the ipsilateral R1 and
bilateral R2, have central generators in the brainstem and are
modulated by supratentorial and basal ganglia structures [8]. The
BR reﬂects the integrity of the brainstem circuits or at least theserved.
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segmental and suprasegmental structures to some extent.
In this study, we aimed to investigate BR circuit in PME patients
with different etiological factors.
2. Subjects and methods
2.1. Subjects
We prospectively included 17 patients with diagnoses of PME
(8 male, 47.1%) who were examined in our epilepsy outpatient
clinic between June 2009 and June 2012. The diagnoses of PME
were based on clinical ﬁndings and electroencephalography.
Cognitive performance was tested via a clinical interview and
the mini-mental state examination.
The inclusion criteria were as follows:
i. presence of cortical myoclonus conﬁrmed by electrophysiolog-
ical investigations,
ii. presence of any type of drug-resistant seizures,
iii. accompanying neurological ﬁndings, such as cognitive decline
and truncal or extremity ataxia,
iv. age >5 years or <55 years.
The exclusion criteria were as follows:
i. presence of any other diagnosis for myoclonus,
ii. presence of any other neurological disorder (e.g., cerebrovas-
cular disease, multiple sclerosis, organic brain disease, etc.),
iii. presence of any contraindication for electrophysiological
investigations.
For comparison, we included 41 healthy age- and gender-
matched volunteers (18 male, 43.9%) who did not have any
neurological or systemic diseases.
This study was approved by the local ethical committee.
Regarding the healthy subjects, all participants provided informed
consent. Regarding the PME group, both the patients and their
family members provided informed consent.
2.2. Clinical and routine electrophysiological evaluation
The age at onset, seizure semiology, detailed clinical history,
antiepileptic drug (AED) use, family history, ﬁndings from
electroencephalography (EEG) and MRI, and the presence of giant
somatosensory evoked potentials (SEP) were noted. Axillary sweat
gland biopsies and muscle biopsies were performed to determine
the speciﬁc subtypes. Selected cases were referred for genetic
analysis. The PME patients without speciﬁc diagnoses despite the
extensive evaluations were classiﬁed as probable PME.
3. Methods
3.1. Blink reﬂex
The electrophysiological recordings were performed using Ag–
AgCl cutaneous EMG recording electrodes (Neuropack S-MEB-
5504K, Nihon Kohden Corporation, Tokyo, Japan) according to
standard techniques [9]. The active electrode was placed on the
lower eyelid, the reference electrode was placed on the lateral
orbital margin, and the ground electrode was positioned on the
sternum. The trigeminal nerve was percutaneously stimulated on
the supraorbital margin. Single electrical stimuli of 0.2 ms in
duration and an intensity of three times the R2 threshold
(8–14 mA) were applied. Five consecutive responses wererecorded with random inter-stimulus intervals of at least 20 s.
Reﬂex responses were deﬁned as deﬂections of at least 50 mV from
the baseline. The ﬁlter settings were 3 kHz high-cut and 20 Hz low-
cut. The analysis time was 10 ms/div, and the sensitivity was
200 mV.
The onset latencies, durations and amplitudes of responses
were measured using cursors. The amplitudes were calculated
peak-to-peak.
3.2. Statistical analysis
The data analyses were performed using the SPSS 15 statistical
software package (SPSS Inc., Chicago, IL, USA).
The mean onset latencies, durations and amplitudes of the
responses were compared between the patients and healthy
subjects using independent t-tests for quantitative data and chi-
square tests for qualitative data.
The mean onset latencies, durations and amplitudes of the
responses were also compared between the patients with and
without speciﬁc diagnoses using independent t-tests for quantita-
tive data and chi-square tests for qualitative data.
Prolonged latencies and absences of responses were catego-
rized as abnormal.
Clinical and demographical features, such as age, gender,
disease duration, seizure types, neurological examination ﬁndings,
AEDs, SEP ﬁndings, and MRI ﬁndings were compared between the
patients with normal and abnormal R2s using independent t-tests
for quantitative data and chi-square tests for qualitative data.
The correlation between disease duration and R2 latency was
analyzed using a Pearson correlation test.
Regression analyses were performed using the variables of
generalized tonic-clonic seizures (GTCSs), absence seizures,
automatisms, age at seizure onset, disease duration and use of
AEDs, to understand the effects of these variables on the abnormal
R2s.p values 0.05 were accepted as signiﬁcant. All values are
presented as the mean  the SD.
4. Results
4.1. Clinical evaluation
GTCS were the second most frequent seizure type after
myoclonic seizures (n = 16, 94.1%). Absence seizures were present
in 6 patients (35.3%) and two patients had automatisms (11.8%).
The neurological examinations revealed cognitive decline in 13
patients (76.5%), gait difﬁculties in 9 (52.9%), pyramidal ﬁndings in
6 (35.3%), extrapyramidal ﬁndings in 5 (29.4%), speech problems in
7 (41.2%), nystagmus in 4 (23.5%), extremity ataxia in 5 (29.4%) and
cranial nerve palsy in 1 patient (5.9%). There were no patients with
mental retardation. The cognitive deﬁcits were mild and involved
executive, planning and memory functions.The clinical, electro-
encephalography and neuroimaging ﬁndings are presented in
Table 1.
Ten patients had deﬁnitive diagnoses of speciﬁc PME subtypes
including the following: 5 patients with Lafora disease, 3 patients
with adult-onset NCL and 2 patients with ULD. Genetic analysis
revealed EPM2A gene mutation in two LD patients and homozy-
gous mutations of the CLN6 gene in siblings with NCL. The
remaining patients (n = 7) did not have speciﬁc diagnoses and were
classiﬁed as probable PME.
Twelve patients (70.6%) were using multiple AEDs. The
medications included valproic acid (76.5%), levetiracetam
(47.1%) and clonazepam (11.8%). One patient was using all three
drugs. Clonazepam was the only add-on treatment. Three patients
were using only levetiracetam because valproic acid had to be
discontinued due to side effects. Three patients had previously
Table 1
Demographical and clinical features of participants.
Patients Healthy subjects p
Mean age (SD), years 26.2 (9.6) 31.0 (11.6) 0.132
Age range, years 13–54 11–58
Gender M/F (%) 8/9 (47.1/52.9) 18/23 (43.9/56.1) 0.826
Age at seizure onset, years 18.3 (12.6) –
Age at diagnosis, years 15.1 (11.1) –
Seizure types, n (%)
GTCS 16 (94.1) –
Absence 6 (35.3) –
Automatisms 2 (11.8) –
Neurological examination, n (%)
Cognitive decline 13 (76.5) –
Gait difﬁculty 9 (52.9) –
Dysarthria 7 (41.2) –
Pyramidal ﬁndings 6 (35.3) –
Extrapyramidal ﬁndings 5 (29.4) –
Extremity ataxia 5 (29.4) –
Nystagmus 4 (23.5) –
Cranial nerve palsy 1 (5.9) –
Electroencephalography
Generalized ED 7 (41.2) –
Focal/multifocal ED 6 (36.3) –
Bioelectrical disorg. 5 (29.4) –
Fotic sensitivity 3 (17.6) –
Brain MRI
Normal 15 (88.2) –
Cortical atrophy 1 (5.9) –
Cerebellar atrophy 1 (5.9) –
SEP
Giant SEP 10 (58.8) –
Medications
Multiple 12 (70.6) –
Vaproic acid 13 (76.5) –
Levetiracetam 8 (47.1) –
Clonazepam 2 (11.8) –
M, male; F, female; GTCS, generalized tonic clonic seizures; ED, epileptiform
discharges; disorg., disorganization; MRI, magnetic resonance imaging; SEP,
somatosensory evoked potentials.
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ineffectiveness before the electrophysiological investigation. No
patient was receiving vagal nerve stimulation.
4.2. Electrophysiological ﬁndings
The R1 and R2 components were obtained in all of the healthy
subjects. The mean latencies are presented in Table 2. In contrast,
the R1 component was not obtained on one side in one patient
(5.9%). The R2 and R2c components were not recorded in twoTable 2
Parameters of blink reﬂex in patients and healthy subjects.
Patients Healthy subjects p
R R1 latency, ms 10.5  0.9 10.1  1.7 0.400
L R1 latency, ms 10.5  0.9 10.3  0.9 0.560
R R2 latency, ms 39.4  7.5 31.8  3.7 0.000*
L R2 latency, ms 38.7  8.0 31.6  3.4 0.000*
R R2 amplitude, mV 248.0  149.9 362.5  143.7 0.064
L R2 amplitude, mV 287.8  127.7 412.0  105.2 0.021**
R R2 duration, ms 57.2  10.5 53.0  12.0 0.748
L R2 duration, ms 50.5  13.1 53.8  13.1 0.856
R R2C latency, ms 41.1  7.4 31.9  3.8 0.000*
L R2C latency, ms 40.7  7.7 32.1  3.8 0.000*
Abnormal R2, % 58.8 0 0.000*
Abnormal R2C, % 58.8 0 0.000*
R, right; L, left.
* p < 0.001.
** p < 0.050.patients (11.8%). Both of these patients had Lafora disease, and
they were 23 and 17 years old. Both of these patients were using
multiple AEDs. One had cranial nerve and cerebellar involvement
whereas the other had a cognitive deﬁcit. The mean latencies of the
bilateral R1s were similar in patients and healthy subjects. The
mean latencies of the bilateral R2 and R2c components were
signiﬁcantly longer in the patients than in the healthy subjects
(Table 2). The durations of the R2 responses were similar between
groups, whereas the amplitudes of the bilateral R2 responses were
diminished in the patients compared with the healthy subjects. In
7 patients (58.8%), the R2 was abnormal; it was bilaterally
prolonged in six patients and absent in one patient. The R2c was
also prolonged in 5 patients and absent in two.
The mean latencies of all of the components of the BR and the
amplitudes and durations of the R2s were similar between the
patients with speciﬁc diagnoses and the patients with probable
PME. The subgroups of PME patients also did not exhibit any
differences regarding these parameters. However, R2 and R2c
abnormalities were more common in the patients with speciﬁc
diagnoses (R2: 60.0% vs 14.3%, p = 0.059; R2c: 66.7% vs 14.3%,
p = 0.036).
In the group with R2 abnormalities, the use of multiple AEDs
(100% vs 50%, p = 0.026) was more frequent than among those with
normal R2s. The disease durations were also longer in the group
with abnormal R2s (7.9  5.8 vs 15.8  10.0, p = 0.050). Age, gender,
other seizure types, the use of each AED, and the giant SEPs were not
different between the groups with normal and abnormal R2s
(Table 3). As the disease duration increased, the latencies of both
the right and left BR R2 components were prolonged (Pearson
correlation, right: 0.514, left: 0.549, p right = 0.050, p left = 0.034).
However, disease duration was not correlated with either the right or
left R2c latency (Pearson correlation, right: 0.106, left: 0.093, p
right = 0.744 and p left = 0.762).
Although this difference was not signiﬁcant, the patients who
were using multiple AEDs had longer disease durations.
The regression analysis revealed that the disease duration
(p = 0.028) and the use of multiple AEDs (p = 0.013) were
independently related to abnormal R2s (Table 4).
5. Discussion
The major ﬁndings of this study are the signiﬁcantly prolonged
latencies of the R2 and R2c components of the BR and the reduced
amplitudes of the R2 despite normal R1 responses. The use of
multiple AEDs was more frequent, and the disease durations were
longer among the patients with abnormal R2s.Table 3
Comparisons of clinical ﬁndings between patients with abnormal R2 and normal R2.
Patients with
abnormal R2s
n = 7
Patients with
normal R2s
n = 10
p
Age, years 24.3  8.5 23.4  6.2 0.180
Gender, M/F, n (%) 3/4 5/5 0.581
Use of multiple AEDs, n (%) 100 50 0.026**
Disease duration, years 15.8  10.0 7.9  5.8 0.050**
Presence of automatisms, n (%) 0 2 (20.0) 0.331
Presence of GTCS, n (%) 7 (100) 9 (90.0) 0.588
Use of valproic acid, n (%) 5 (71.4) 8 (80.0) 0.682
Use of levetiracetam, n (%) 5 (71.4) 3 (30.0) 0.117
Cognitive deﬁcit, n (%) 5 (71.4) 8 (80.0) 0.559
Abnormal MRI ﬁndings, n (%) 1 (14.3) 1 (10.0) 0.700
Giant SEP 5 (71.4) 5 (50.0) 0.354
M, male; F, female; AED, antiepileptic drugs; MRI, magnetic resonance imaging;
SEP, somatosensory evoked potential.
** p < 0.050.
Table 4
Analysis of effect of clinical features on abnormal R2s.
Beta Sig.
Absence seizure 0.142 0.505
GTCS 0.216 0.206
Automatism 0.357 0.093
Disease durationa 0.422 0.028**
Use of multiple AEDs 0.527 0.013**
a Disease duration was grouped as 0–5 years, 5–10 years, >10 years.
GTCS, generalized tonic clonic seizure; AEDs, antiepileptic drugs.
** p < 0.050.
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is used to examine the functions of the brainstem in routine clinical
practice. The BR is most frequently elicited by supraorbital
electrical stimulation. The afferent and efferent pathways of both
the R1 and R2 components are the ophthalmic branch of the
trigeminal nerve and the facial nerve, respectively. The central
generator of the R1 is located in the pons, whereas the R2 pathway
involves numerous synapses bilaterally in the brainstem reticular
formation from the pons to the medulla. Therefore, the latency of
the R1 is shorter, and this response is unilateral. The latency and
characteristics of the R1 do not change with repeated stimulation
because the number of synapses is limited [9]. The latencies and
presences of the R1 and R2 reﬂect the integrity of the related
circuits. Thus, we can conclude that the reﬂex circuitry of the R1
was intact in all of our patients. Our results support the integrities
of the afferent and efferent pathways and the motor neurons in the
pons that innervate the orbicularis oculi muscle because the R1
was normal in all of the patients with the exception of one in whom
the R1 could not be obtained on one side.
In contrast, the number of synapses and interneurons in the R2
pathway are high, which leads to responses with longer latencies,
longer durations, and multiple phases. The characteristics of the
response also change after each stimulus. Consequently, the R2 is
more affected by the modulatory effects of the rostral brainstem,
speciﬁcally the superior colliculus, raphe nucleus and basal ganglia
[10,11]. The latency and presence of the R2 also reﬂects the
integrity of the related circuit. Longer latencies may suggest a
structural lesion or a functional inhibition in the pathway. There
are different methods to investigate the excitability of the BR
pathway [12]. The amplitude, area and duration of the R2 may
indicate the excitability of its pathway and the related rostral
structures. Therefore, the abnormal ﬁndings regarding the R2
parameters observed in our study suggest the suppression of the
interneuronal network in the reticular formation of the brainstem
and impairments of the suprasegmental control mechanisms.
The excitability of the BR has been used to monitor the
functional status of the brainstem in various neurodegenerative
diseases [12]. Increased activity of the superior colliculus
suppresses the excitability of the R2 [11]. For example, in
Huntington’s disease, the loss of striatal neurons has been
hypothesized to increase collicular activity and lead to a
hypoexcitable BR [13]. Additionally, direct inhibition of the
brainstem interneurons in the reticular formation due to either
functional or structural changes may also result in the suppression
of the R2. Koutroumanidis et al. [7] demonstrated suppressed R1
and R2 components in patients with histochemically and
genetically conﬁrmed mitochondrial myopathies, and two of these
patients had diagnoses of myoclonic epilepsy with ragged red
ﬁbers syndrome. These authors attributed the results from their
patients, including those with apparently pure myopathy, to
clinically silent brainstem impairments. Although our patients did
not have any brainstem or basal ganglia lesions, there were
signiﬁcant abnormalities of the R2 and R2c components, which
support the idea of Koutroumanidis et al. [7] that brainsteminvolvement can be functionally observed in cases of PME even
without neuroimaging ﬁndings.
A previous report indicated that gender does not affect the BR
[14], and we also observed no effect of gender. The observed
increases in abnormalities with longer disease durations were not
surprising because degeneration probably increases over years.
The use of valproic acid or levetiracetam did not seem to have any
effect; however, the use of multiple AEDs was associated with
abnormally suppressed R2s. The absences of the R2 and R2c were
probably related to the use of multiple AEDs. AEDs have been
shown to suppress the polysynaptic pathway of the R2 [15], which
is not surprising because AEDs may affect the levels of dopamine
and GABA, which are the main neurotransmitters in the
modulatory pathways of the BR.
Accompanying neurological ﬁndings, such as ataxia, are
features in myoclonic epilepsies with poor prognoses which are
related to the pathological involvements of different parts of brain
[16]. As we previously mentioned, neuroimaging and autopsy
studies have also suggested brainstem involvement. Therefore, we
believe that the inhibition of the R2 is most likely related to
degenerative changes in the brainstem and rostral structures that
are beyond the imaging capacity of MRI.
Regarding the clinical courses, the patients with LD exhibited
more severe neurological symptomatology and more intractable
seizures. However, we did not ﬁnd any differences between the
patients with speciﬁc diagnoses, which could be a consequence of
the major limitation of this study; i.e., the entire group was rather
heterogeneous, and the subgroups included small numbers of
patients. Additionally, the electrophysiological abnormalities were
less remarkable in the patients with probable PME, which
represents a second limitation. Although the patients who were
categorized as probable PME had all of the features speciﬁc to PME,
clinical classiﬁcation is associated with the problem of including
patients without PME. Nevertheless, the statistical analyses that
were performed after excluding this group conﬁrmed the presence
of abnormal R2 ﬁndings in PME.
In conclusion, the abnormalities of the R2 and R2c components
of the BR conﬁrmed the inhibition of the reticular formation in
PME, and this inhibition probably was primarily due to the disease
process and partially due to the use of AEDs.
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